VRTX:Vertex Pharmaceuticals Inc Snapshot | Charting | News | Options
$391.02 NASDAQ 12:56p ET
July 22 '25 		Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulat... PR Newswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on VRTX
    No News Available
    Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancer...
    8:30a ET July 9 '25 PR Newswire Europe
    Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancer...
    8:30a ET July 9 '25 PR Newswire
    Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancer...
    8:30a ET July 9 '25 CNW Group
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in...
    8:30a ET July 7 '25 PR Newswire Europe
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in...
    8:30a ET July 7 '25 CNW Group
    Precision Genetic Medicine Platform Could Disrupt Standard of Care in...
    8:30a ET July 7 '25 PR Newswire
    Vertex Presents Longer-Term Data at the 2025 European Hematology Asso...
    9:39a ET July 3 '25 CNW Group
    Vertex Presents Longer-Term Data at the 2025 European Hematology Asso...
    9:39a ET July 3 '25 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2025 All rights reserved.